Cargando…
Novel Synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth
Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in malignant tumors and plays important roles in multiple aspects of cancer aggressiveness. Thus, targeting STAT3 promises to be an attractive strategy for treatment of advanced metastatic tumors. Bisindolylmaleim...
Autores principales: | Li, Xia, Ma, Hongguang, Li, Lin, Chen, Yifan, Sun, Xiao, Dong, Zizheng, Liu, Jing-Yuan, Zhu, Weiming, Zhang, Jian-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934316/ https://www.ncbi.nlm.nih.gov/pubmed/29456240 http://dx.doi.org/10.1038/s41388-017-0076-0 |
Ejemplares similares
-
Bisindolylmaleimides New Ligands of CaM Protein
por: Sosa-Peinado, Alejandro, et al.
Publicado: (2022) -
Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
por: Hua, Yaping, et al.
Publicado: (2022) -
YQ36: A Novel Bisindolylmaleimide Analogue Induces KB/VCR Cell Death
por: Cao, Ji, et al.
Publicado: (2009) -
Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia
por: Zhang, Xin, et al.
Publicado: (2016) -
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
por: de Araujo, Elvin D., et al.
Publicado: (2019)